Resources

A student hypothesizes that overexpressing the multidrug resistance transporter gene ABCB1 (P-glycoprotein) will uniformly decrease the intracellular concentration of all hydrophobic chemotherapeutic agents. In a cultured leukemic cell line, ABCB1 expression increases 10.010.0-fold, leading to an active drug efflux clearance rate of CLefflux=4.50×10−5 L/(min⋅106 cells)CL_{\text{efflux}} = 4.50 \times 10^{-5}\text{ L}/(\text{min}\cdot 10^6\text{ cells}) for daunorubicin. However, for a second hydrophobic agent, drug XX, the transporter exhibits zero substrate affinity (Km→∞K_m \to \infty), while drug XX passively diffuses across the membrane at an influx permeability-surface area product of PS=2.00×10−5 L/(min⋅106 cells)P S = 2.00 \times 10^{-5}\text{ L}/(\text{min}\cdot 10^6\text{ cells}) without active export. If the extracellular concentration of drug XX is maintained at 5.00 μM5.00\,\mu\mathrm{M}, calculate the steady-state intracellular concentration of drug XX in  μM\,\mu\mathrm{M} in the ABCB1-overexpressing cells, assuming equilibrium passive diffusion across the plasma membrane.

Answer and steps

Final answer

5.00 μM5.00\,\mu\mathrm{M}

Steps

01

Identify the Transporter Specificity for Drug XX

Transporters such as P-glycoprotein (encoded by the ABCB1 gene) depend on specific substrate binding to catalyze active efflux. The affinity of an enzyme or transporter for a compound is reflected inversely by its Michaelis constant, KmK_m:

  • For daunorubicin, ABCB1 overexpression mediates active drug clearance (CLefflux>0CL_{\text{efflux}} > 0).
  • For drug XX, the transporter exhibits zero affinity (Km→∞K_m \to \infty). Consequently, P-glycoprotein cannot engage drug XX, making the active efflux clearance for drug XX zero:

CLefflux, X=0CL_{\text{efflux, } X} = 0

02

Formulate the Mass Balance for Passive Diffusion at Steady State

Because active transport does not occur for drug XX, its movement across the plasma membrane is governed solely by passive bidirectional diffusion.

The passive influx rate (JinJ_{\text{in}}) and passive efflux rate (JoutJ_{\text{out}}) are given by Fick's first law using the permeability-surface area product (PSPS):

Jin=PS⋅[X]extracellularJ_{\text{in}} = PS \cdot [X]_{\text{extracellular}}

Jout=PS⋅[X]intracellularJ_{\text{out}} = PS \cdot [X]_{\text{intracellular}}

At steady-state equilibrium, the net flux across the membrane is zero:

Jnet=Jin−Jout=0J_{\text{net}} = J_{\text{in}} - J_{\text{out}} = 0

PS⋅[X]extracellular−PS⋅[X]intracellular=0PS \cdot [X]_{\text{extracellular}} - PS \cdot [X]_{\text{intracellular}} = 0

03

Calculate the Intracellular Concentration

Dividing by PSPS simplifies the equation to:

[X]intracellular=[X]extracellular[X]_{\text{intracellular}} = [X]_{\text{extracellular}}

Given that [X]extracellular=5.00 μM[X]_{\text{extracellular}} = 5.00\text{ }\mu\text{M}:

[X]intracellular=5.00 μM[X]_{\text{intracellular}} = 5.00\text{ }\mu\text{M}

Key Takeaway: A gene expression change (such as ABCB1 overexpression) alters cellular phenotype only for ligands or substrates recognized by the encoded protein. Hydrophobicity alone is insufficient for transport; without substrate specificity, passive equilibrium dictates that intracellular and extracellular concentrations remain equal.

Typical errors

OverviewACEpath Teacher's Diagnosis

01 The student erroneously applies the active efflux clearance of daunorubicin to drug X despite drug X having zero substrate affinity for the transporter.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Incorrect
  1. Step 1

    PS⋅[X]out=(PS+CLefflux)⋅[X]in  ⟹  [X]in=[X]out⋅PS(PS+CLefflux)PS \cdot [X]_{\text{out}} = (PS + CL_{\text{efflux}}) \cdot [X]_{\text{in}} \implies [X]_{\text{in}} = [X]_{\text{out}} \cdot \frac{PS}{(PS + CL_{\text{efflux}})}

    Correct

    Jin=Jout  ⟹  PS⋅[X]out=PS⋅[X]in  ⟹  [X]in=[X]outJ_{\text{in}} = J_{\text{out}} \implies PS \cdot [X]_{\text{out}} = PS \cdot [X]_{\text{in}} \implies [X]_{\text{in}} = [X]_{\text{out}}

    You included an active efflux clearance term (CLeffluxCL_{\text{efflux}}) for drug XX. However, the problem specifies that drug XX has zero substrate affinity for ABCB1 (Km→∞K_m \to \infty) and undergoes no active export, meaning CLefflux=0CL_{\text{efflux}} = 0.

  2. Step 2

    [X]in=5.00⋅2.00×10−52.00×10−5+4.50×10−5[X]_{\text{in}} = \frac{5.00 \cdot 2.00 \times 10^{-5}}{2.00 \times 10^{-5} + 4.50 \times 10^{-5}}

    Correct

    [X]in=[X]out=5.00 \muM[X]_{\text{in}} = [X]_{\text{out}} = 5.00\text{ \mu M}

    You substituted the active efflux clearance value determined for daunorubicin (4.50×10−5 L/(min⋅106 cells)4.50 \times 10^{-5}\text{ L}/(\text{min}\cdot 10^6\text{ cells}) into the formula for drug XX, which carried forward the assumption of active transport.

  3. Step 3

    [X]in=1.54 \muM[X]_{\text{in}} = 1.54\text{ \mu M}

    Correct

    [X]in=5.00 \muM[X]_{\text{in}} = 5.00\text{ \mu M}

    You evaluated the arithmetic correctly for your substituted expression, but the resulting concentration is incorrect due to the inclusion of daunorubicin's efflux clearance.

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly formulated the general steady-state mass balance between passive influx and total clearance.

You solved for the intracellular concentration algebraically before substituting values.

You executed the arithmetic calculation accurately based on your substituted numbers.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Substrate Specificity Misapplication

no

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You assumed that overexpressing ABCB1 universally confers active efflux to all hydrophobic molecules, overlooking that transporter-mediated clearance strictly requires substrate recognition and binding affinity (Km<∞K_m < \infty).

REASONING PATH
Your ACEpath teacher’s suggested approach
Transporter Substrate Specificity
  • Active transport requires specific chemical recognition and binding; high hydrophobicity alone does not guarantee that a compound is an ABCB1 substrate if Km→∞K_m \to \infty.

  • Check whether the specific molecule has documented affinity (Km<∞K_m < \infty) for the transporter before assigning an active efflux rate.

Passive Equilibrium Balance
  • In the absence of active transport, passive bidirectional diffusion across a membrane continues until intracellular and extracellular concentrations equalize ([C]in=[C]out[C]_{\text{in}} = [C]_{\text{out}}).

  • Set CLefflux=0CL_{\text{efflux}} = 0 whenever a transporter cannot bind the solute, reducing the flux balance directly to [X]in=[X]out[X]_{\text{in}} = [X]_{\text{out}}.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Identify that drug XX has zero affinity for ABCB1 (Km→∞K_m \to \infty), so its active efflux clearance is CLefflux=0CL_{\text{efflux}} = 0.

  2. Write the steady-state flux balance governed exclusively by passive diffusion: PS⋅[X]out=PS⋅[X]inPS \cdot [X]_{\text{out}} = PS \cdot [X]_{\text{in}}.

  3. Divide both sides by PSPS to obtain [X]in=[X]out[X]_{\text{in}} = [X]_{\text{out}}.

  4. Substitute [X]out=5.00 \muM[X]_{\text{out}} = 5.00\text{ \mu M} directly.

Final answer

5.00 \muM5.00\text{ \mu M}

NEXT STEPS
Final Takeaways from Your Teacher
  • Review how enzyme and transporter kinetics depend on substrate specificity (KmK_m) rather than general physicochemical classes alone.

  • Practice distinguishing between passive membrane diffusion equilibrium and active steady-state concentration gradients.

  • Complete the targeted flashcards and practice problems below to master transporter-mediated cell trait changes.

OverviewACEpath Teacher's Diagnosis

02 The student assumes the 10.0-fold overexpression of ABCB1 universally reduces the intracellular drug concentration by a factor of 10.0.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Incorrect
  1. Step 1

    [X]in=[X]out10.0[X]_{\text{in}} = \frac{[X]_{\text{out}}}{10.0}

    Correct

    CLefflux, X=0  ⟹  Jin=Jout  ⟹  [X]in=[X]outCL_{\text{efflux, } X} = 0 \implies J_{\text{in}} = J_{\text{out}} \implies [X]_{\text{in}} = [X]_{\text{out}}

    You applied the 10.0-fold gene overexpression factor universally to reduce the intracellular concentration of drug XX. Because the problem specifies that the transporter has zero substrate affinity (Km→∞K_m \to \infty) for drug XX, the transporter cannot pump drug XX out regardless of how heavily ABCB1 is overexpressed.

  2. Step 2

    [X]in=5.0010.0=0.50 \muM[X]_{\text{in}} = \frac{5.00}{10.0} = 0.50\text{ \mu M}

    Correct

    [X]in=5.00 \muM[X]_{\text{in}} = 5.00\text{ \mu M}

    You calculated [X]in=0.50 \muM[X]_{\text{in}} = 0.50\text{ \mu M} by evaluating your incorrect relation. Under uninhibited passive diffusion equilibrium, [X]in[X]_{\text{in}} equals [X]out[X]_{\text{out}}, which is 5.00 \muM5.00\text{ \mu M}.

WHAT YOU DID WELL
Compliments from Your Teacher

You identified the extracellular concentration [X]out=5.00 \muM[X]_{\text{out}} = 5.00\text{ \mu M} from the problem statement.

You carried out your arithmetic division correctly.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Substrate Specificity Neglect

none

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You assumed that overexpressing a transport protein automatically alters the distribution of all hydrophobic molecules, overlooking the requirement for specific substrate-transporter binding (KmK_m).

REASONING PATH
Your ACEpath teacher’s suggested approach
Substrate Specificity of Transport Proteins
  • An active transporter only changes cellular drug levels if the drug is an actual substrate (finite KmK_m). If Km→∞K_m \to \infty, active clearance is zero.

  • Always check whether the molecule of interest binds the transporter before applying any clearance or expression-level fold changes.

Passive Diffusion Equilibrium
  • For an uncharged solute moving solely by passive diffusion across a membrane, steady-state net flux is zero when [C]in=[C]out[C]_{\text{in}} = [C]_{\text{out}}.

  • Set intracellular concentration equal to extracellular concentration when no active transport, metabolism, or electrochemical gradients are present.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Identify that zero substrate affinity (Km→∞K_m \to \infty) means active efflux clearance for drug XX is CLefflux=0CL_{\text{efflux}} = 0.

  2. Write the steady-state passive diffusion flux balance: Jnet=PS([X]out−[X]in)=0J_{\text{net}} = PS([X]_{\text{out}} - [X]_{\text{in}}) = 0.

  3. Solve for the intracellular concentration: [X]in=[X]out=5.00 \muM[X]_{\text{in}} = [X]_{\text{out}} = 5.00\text{ \mu M}.

Final answer

5.00 \muM5.00\text{ \mu M}

NEXT STEPS
Final Takeaways from Your Teacher
  • Review the distinction between general physicochemical properties (like hydrophobicity) and biochemical specificity (enzyme/transporter binding pockets).

  • Practice identifying when a membrane solute is governed solely by Fickian passive diffusion versus active carrier-mediated flux.

Lock it in

Similar question

01

A leukemic cell line overexpresses ABCB1. Drug AA is a known P-glycoprotein substrate with active efflux clearance CLefflux=6.00×10−5 L/(min⋅106 cells)CL_{\text{efflux}} = 6.00 \times 10^{-5}\text{ L}/(\text{min}\cdot 10^6\text{ cells}) and passive permeability PS=3.00×10−5 L/(min⋅106 cells)PS = 3.00 \times 10^{-5}\text{ L}/(\text{min}\cdot 10^6\text{ cells}). If [A]out=6.00 \muM[A]_{\text{out}} = 6.00\text{ \mu M}, calculate the steady-state intracellular concentration [A]in[A]_{\text{in}} in \muM\text{\mu M}.

Answer

2.00 \muM2.00\text{ \mu M}. Set up the steady-state flux balance: PS⋅[A]out=(PS+CLefflux)⋅[A]inPS \cdot [A]_{\text{out}} = (PS + CL_{\text{efflux}}) \cdot [A]_{\text{in}}. Rearranging gives [A]in=[A]out⋅PSPS+CLefflux=6.00⋅3.00×10−53.00×10−5+6.00×10−5=6.00⋅13=2.00 \muM[A]_{\text{in}} = [A]_{\text{out}} \cdot \frac{PS}{PS + CL_{\text{efflux}}} = 6.00 \cdot \frac{3.00 \times 10^{-5}}{3.00 \times 10^{-5} + 6.00 \times 10^{-5}} = 6.00 \cdot \frac{1}{3} = 2.00\text{ \mu M}.

02

Cells expressing the transporter BCRP (ABCG2ABCG2) are exposed to hydrophobic Drug ZZ ([Z]out=4.00 \muM[Z]_{\text{out}} = 4.00\text{ \mu M}, PS=1.80×10−5 L/(min⋅106 cells)PS = 1.80 \times 10^{-5}\text{ L}/(\text{min}\cdot 10^6\text{ cells})). Competitive binding assays show Drug ZZ does not bind BCRP (Km→∞K_m \to \infty). An inhibitor of BCRP is then added to the medium. Does the intracellular concentration of Drug ZZ change? Explain quantitatively.

Answer

No, [Z]in[Z]_{\text{in}} remains 4.00 \muM4.00\text{ \mu M}. Because Drug ZZ has zero affinity for BCRP, its active efflux clearance was already zero (CLefflux=0CL_{\text{efflux}} = 0). Thus, passive diffusion maintained [Z]in=[Z]out=4.00 \muM[Z]_{\text{in}} = [Z]_{\text{out}} = 4.00\text{ \mu M}, and inhibiting BCRP has no effect on its transport.

03

A cell line actively imports Solute MM via a saturable influx carrier with Vmax⁡=1.00×10−4 \mumol/(min⋅106 cells)V_{\max} = 1.00 \times 10^{-4}\text{ \mu mol}/(\text{min}\cdot 10^6\text{ cells}) and Km=2.00 \muMK_m = 2.00\text{ \mu M}. Solute MM also diffuses passively in both directions with PS=2.00×10−5 L/(min⋅106 cells)PS = 2.00 \times 10^{-5}\text{ L}/(\text{min}\cdot 10^6\text{ cells}), and has zero affinity for all efflux pumps. If [M]out=2.00 \muM[M]_{\text{out}} = 2.00\text{ \mu M} at steady state, calculate [M]in[M]_{\text{in}} in \muM\text{\mu M}.

Answer

4.50 \muM4.50\text{ \mu M}. Total influx equals passive influx plus carrier-mediated influx: Jin=PS⋅[M]out+Vmax⁡⋅[M]outKm+[M]out=(2.00×10−5)(2.00)+(1.00×10−4)(2.00)2.00+2.00=4.00×10−5+5.00×10−5=9.00×10−5 \mumol/(min⋅106 cells)J_{\text{in}} = PS \cdot [M]_{\text{out}} + \frac{V_{\max} \cdot [M]_{\text{out}}}{K_m + [M]_{\text{out}}} = (2.00 \times 10^{-5})(2.00) + \frac{(1.00 \times 10^{-4})(2.00)}{2.00 + 2.00} = 4.00 \times 10^{-5} + 5.00 \times 10^{-5} = 9.00 \times 10^{-5}\text{ \mu mol}/(\text{min}\cdot 10^6\text{ cells}). At steady state with passive efflux only: Jout=PS⋅[M]in=JinJ_{\text{out}} = PS \cdot [M]_{\text{in}} = J_{\text{in}}. Therefore, [M]in=9.00×10−52.00×10−5=4.50 \muM[M]_{\text{in}} = \frac{9.00 \times 10^{-5}}{2.00 \times 10^{-5}} = 4.50\text{ \mu M}.

Loading workspace…